Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2019
vol. 84 Urogenital radiology
abstract:
Review paper
MRI-derived markers for predicting a decline in renal function in patients with autosomal dominant polycystic kidney disease
Ewa Banach-Ambroziak
1
,
Magdalena Jankowska
2
,
Małgorzata Grzywińska
3
,
Joanna Pieńkowska
4
,
Edyta Szurowska
4
1.
University Medical Centre of Gdansk, Poland
2.
Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Poland
3.
Department of Human Physiology, Medical University of Gdansk, Poland
4.
Second Department of Radiology, Medical University of Gdansk, Poland
Pol J Radiol 2019; 84: e289-e294
Online publish date: 2019/08/09
View full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Autosomal dominant polycystic kidney disease (ADPKD) constitutes the fourth cause of end-stage renal disease in Europe. The course of the disease varies widely among patients with ADPKD. Due to the emergence of new possibilities of pharmacotherapy, it has become crucial to identify the group of patients with the fastest rate and risk of disease progression. This particular group of patients will benefit most from the therapy and they are the best candidates for clinical trials. At the early stages of ADPKD typical markers of severity and progression of the disease remain unchanged in contrast to the kidney volume, which increases continuously in an exponential way. Therefore, the use of height-adjusted total kidney volume as a biomarker should become a mandatory diagnostic option. Also, quantitative MRI techniques are promising biomarkers for the evaluation of disease severity and could provide additional insights into its course.
keywords:
autosomal dominant polycystic kidney disease, total kidney volume, MRI |